153 related articles for article (PubMed ID: 1271893)
41. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
Hager JC; Miller FR; Heppner GH
Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
[No Abstract] [Full Text] [Related]
42. Antitumor antibody synthesis in vitro induced in mouse spleen cells by xenogeneic immune RNA.
Kern DH; Pilch YH
J Natl Cancer Inst; 1978 Mar; 60(3):599-603. PubMed ID: 625065
[No Abstract] [Full Text] [Related]
43. Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.
Pilch YH; Myers GH; Sparks FC; Golub SH
Curr Probl Surg; 1975 Jan; ():1-46. PubMed ID: 236150
[No Abstract] [Full Text] [Related]
44. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
45. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
Veltman LL; Kern DH; Pilch YH
Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321
[No Abstract] [Full Text] [Related]
46. Specific tumor-induced suppression of lymphocyte activity in the antibody-dependent tumoricidal reaction.
Stolfi RL; Stolfi LM; Fugmann RA; Martin DS
Int J Cancer; 1974 Nov; 14(5):625-32. PubMed ID: 4142474
[No Abstract] [Full Text] [Related]
47. The immunology of cancer.
Angel Basombrío M
J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
[No Abstract] [Full Text] [Related]
48. "Immune" RNA--a new model for the immunotherapy of cancer.
Pilch YH
Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
[No Abstract] [Full Text] [Related]
49. The functions of the macrophage in malignant disease.
Alexander P
Annu Rev Med; 1976; 27():207-24. PubMed ID: 779596
[No Abstract] [Full Text] [Related]
50. Transfer factor: a potential agent for cancer therapy.
LoBuglio AF; Neidhart JA
Med Clin North Am; 1976 May; 60(3):585-90. PubMed ID: 775210
[TBL] [Abstract][Full Text] [Related]
51. Demonstration of tumor-associated transplantation antigens in rat mammary tumors induced by 7,12-dimethylbenz (alpha) anthracene.
Silinskas KC; Fang W; Mukkur TK
Oncology; 1974; 29(4):273-82. PubMed ID: 4842402
[No Abstract] [Full Text] [Related]
52. Corretation between immunosuppression to tumorigenesis. 1. Humoral immunosuppressing factor.
Hakim AA
Eur J Cancer (1965); 1978 Nov; 14(11):1249-60. PubMed ID: 738330
[No Abstract] [Full Text] [Related]
53. Modified tumor cells in the immunotherapy of solid mammary tumors.
Simmons RL; Rios A; Trites P
Med Clin North Am; 1976 May; 60(3):551-65. PubMed ID: 1271892
[No Abstract] [Full Text] [Related]
54. Comparison of the antitumor effects of a synthetic biopolymer and standard adjuvants.
Falk RE; Makowka L; Nossal NA; Rotstein LE; Falk JA
Surgery; 1980 Jul; 88(1):126-36. PubMed ID: 6992317
[TBL] [Abstract][Full Text] [Related]
55. Diminished in vitro toxic effect of phytohaemagglutinin for lymphocytes of rats bearing syngeneic tumours.
Medzihradský J; Babusíková O; Koníková E
Neoplasma; 1973; 20(4):353-61. PubMed ID: 4147074
[No Abstract] [Full Text] [Related]
56. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
57. Relationship between intradermal tumor suppression and tumor immunity.
Bartlett GL; Kreider JW; Purnell DM
J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
[TBL] [Abstract][Full Text] [Related]
58. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
Skinner DG; Dekernion JB; Brower PA; Ramming KP; Pilch YH
J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
[TBL] [Abstract][Full Text] [Related]
59. Stimulatory immunotherapy in mammary cancer.
Anderson JM; Kelly F; Wood SE; Halnan KE
Br J Surg; 1974 Oct; 61(10):778-84. PubMed ID: 4137944
[No Abstract] [Full Text] [Related]
60. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
